Development and physicochemical evaluation of pharmacosomes of diclofenac

P. M. Peloso, Strategies and practice for the use of nonsteroidal anti-inflammatory drugs, Scan. J. Rheumatol. 25 (1996) 29-48.10.3109/03009749609097233Search in Google Scholar

A. Figueras, D. Capella, J. M. Castel and J. R. Laporte, Spontaneous reporting of adverse drug reactions to nonsteroidal anti-inflammatory drugs, Eur. J. Clin. Pharmacol. 47 (1994) 297-303; DOI: 10.1007/BF00191158.10.1007/BF00191158Search in Google Scholar

L. M. Lichtenberger, Z. M. Wang, J. J. Romero, C. Ulloa, J. C. Perez, M. N. Giraud and J. C. Barreto, Non steroidal anti-inflammatory drugs (NSAIDs) associate with zwitterionic phospholipids: Insight into the mechanism and reversal of NSAID-induced gastrointestinal injury, Nature Med. 11 (1995) 154-158; DOI: 10.1038/nm0295-154.10.1038/nm0295-154Search in Google Scholar

P. J. Goddard, Y. J. Kao and L. M. Lichtenberger, Luminal surface hydrophobicity of canine gastric mucosa is dependent on a surface mucous gel, Gastroenterology 98 (1990) 361-370.10.1016/0016-5085(90)90826-MSearch in Google Scholar

L. M. Lichtenberger, L. A. Graziani, E. J. Dial, B. D. Butter and B. A. Hills, Role of surface-active phospholipids in gastric cytoprotection, Science 219 (1983) 1327-1329; DOI: 10.1126/science.6828 859.Search in Google Scholar

L. M. Lichtenberger, C. Ulloa, J. J. Romero, A. L. Vanous, J. J. Romero, E. J. Dial, P. A. Illich and E. T. Walters, Zwitterionic phospholipids enhance aspirin's therapeutic activity, as demonstrated in rodent model systems, J. Pharmacol. Exp. Ther. 277 (1996) 1221-1227.Search in Google Scholar

S. S. Biju, S. Talegaonkar, P. R. Mishra and R. K. Khar, Vesicular systems: an overview, Indian J. Pharm. Sci. 68 (2006) 141-153.10.4103/0250-474X.25707Search in Google Scholar

United States Pharmacopoeia 23, National Formulary 18, USP Convention, Rockville (MD) 1999, pp. 1791-1792.Search in Google Scholar

H. Maswadeh, A. Abdulhalim and C. Demetzos, Improvement of encapsulation efficiency of diclofenac sodium into uncoated and chitosan-coated liposomes, Indian J. Pharm. Sci. 66 (2004) 607-612.Search in Google Scholar

L. M. Lichtenberger, C. Ulloa, J. J. Romero, A. L. Vanous, P. A. Illich and E. J. Dial, Nonsteroidal anti-inflammatory drug and phospholipid prodrugs: Combination therapy with antisecretory agents in rats, Gastroenterology 111 (1996) 990-995; DOI: 10.1016/S0016-5085(96)70066-5.10.1016/S0016-5085(96)70066-5Search in Google Scholar

M. Semalty, A. Semalty, D. Singh, T. Chamoli and M. S. M. Rawat, Effect of purity of phospholipids in improving bioavailability performance of aspirin-phospholipid complex, National Convention of Chemistry Teachers (NCCT) Annual Conference and Convention, Nov 8-9 2008, Srinagar (Garhwal), India, Book of Abstracts, Indian Association of Chemistry Teachers, Srinagar 2008, p. 72.Search in Google Scholar

X. Yanyu, S. Yunmei, C. Zhipeng and P. Quineng, The preparation of silybin-phospholipid complex and the study on its pharmacokinetics in rats, Int. J. Pharm. 307 (2006) 77-82; DOI: 10.1016/j.ijpharm.2005.10.001.10.1016/j.ijpharm.2005.10.00116300915Search in Google Scholar

Y. Li, D. J. Yang, S. L. Chen, S. B. Chen and A. S. C. Chan, Comparative physicochemical characterization of phospholipids complex of puerarin formulated by conventional and supercritical methods, Pharm. Res. 25 (2007) 563-577; DOI: 10.1007/s11095-007-9418-x.10.1007/s11095-007-9418-x17828444Search in Google Scholar

K. Maiti, K. Mukherjee, A. Gantait, B. P. Saha and P. K. Mukherjee, Curcumin-phospholipid complex: Preparation, therapeutic evaluation and pharmacokinetic study in rats, Int. J. Pharm. 330 (2007) 155-163; DOI: 10.1016/j.ijpharm.2006.09.025.10.1016/j.ijpharm.2006.09.02517112692Search in Google Scholar

D. J. Jarmer, C. S. Lengsfeld, K. S. Anseth and T. W. Randolph, Supercritical fluid crystallization of griseofulvin: Crystal habit modification with a selective growth inhibitor, J. Pharm. Sci. 94 (2005) 2688-2702; DOI: 10.1002/jps.20463.10.1002/jps.2046316258994Search in Google Scholar